Cell Genesys (CEGE)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Cell Genesys (CEGE)
17 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on CEGE
Most popular authors
(tracked in watchlists)
- Alan Brochstein(222)
- Stockerblog (201)
- Mike Huckman(76)
- TickerSense (49)
- Ohad Hammer(45)
Most commented on authors
- Michael Shulman(17)
- Alan Brochstein(15)
- Ohad Hammer(8)
- Mike Huckman(5)
- Centient Biotech Investor(3)
- Which Has a Better Risk/Reward Ratio - Citigroup or Cell Genesys?
- Cell Genesys’ GVAX: A Multi-Trick Pony
- Cancer Stocks Hammered Once Again
- Antigenics, Dendreon and Cell Genesys Find Hope in Overseas Treatment Approvals
- Russian Roulette Pays Off for Antigenics
- Cancer Stocks Plunge Following ASCO Meeting
- Cancer Stocks on the Go: Winners and Losers
- Six Significant Gene Therapy Stocks
- Five Biopharma Companies Drop on Negative Drug News
- Cancer Stocks Slide Again
-
Cell Genesys, Inc. Q4 2007 Earnings Call Transcript
on Feb 28, 2008 1 Comments
- Biotech Stocks Day-In-Review: Amgen Rises On Speculation Over Patent Suit
- Biotech Week In Review: Barron’s Touts Alzheimers Drugs From Wyeth
- Biotech Day In Review: Genentech Beats Estimates Slightly
- 7 Companies Searching to Treat or Cure Parkinson's
-
Cell Genesys, Inc. Q1 2008 Earnings Call Transcript
on May 18, 2008 1 Comments
- Cancer Stocks Soar With Annual ASCO Meeting
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »